Categories Earnings, Health Care

Bausch Health Companies Inc. (NYSE: BHC): Q4 2019 Earnings Snapshot

— Bausch Health Companies Inc. (NYSE: BHC) reported a loss of $4.30 per share for the fourth quarter of 2019, compared to a loss of $0.98 per share last year, vs. $1.15 per share loss expected.

Bausch Health Companies Inc. (NYSE: BHC): Q4 2019 Earnings Snapshot

— Net loss for the quarter was $1.516 billion, compared to a loss of $344 million a year earlier

— December-quarter revenues increased 5% annually to $2.22 billion, vs. $2.2 billion expected

— Revenue of Bausch + Lomb/International, the main business segment, grew 3% annually; Salix segment revenue was up 21%

— Received FDA approval for ARAZLO Lotion for the topical treatment of acne vulgaris in young adults

— Raised capital allocation for research and development by 14% in fiscal 2019, compared to last year

— Expects full-year 2020 revenues to be in the range of $8.65 billion to $8.85 billion

— Looking for adjusted EBITDA in the range of $3.50 billion to $3.65 billion for fiscal 2020

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text

Also Read:  Silence Therapeutics PLC (SLN) Q2 2020 Earnings Call Transcript

Most Popular

Weibo (WB) reports upbeat Q2 results as pandemic situation stabilizes in China

Chinese social media platform Weibo (NASDAQ: WB) reported a year-over-year decline in non-GAAP EPS and revenue for the second quarter of 2020. However, both the bottom line and topline numbers

Software companies that witnessed growth during the COVID-19 pandemic

The business world experienced a heavy wave of change this year due to the COVID-19 pandemic which led several companies to move their operations online and allow their employees to

Accenture (ACN) drops 7% after missing Q4 estimates and weak guidance

Business consulting services provider Accenture (NYSE: ACN) reported its fourth quarter and fiscal 2020 earnings last Thursday. Accenture's failure to meet the market's earnings and revenue targets and the weak

One thought on “Bausch Health Companies Inc. (NYSE: BHC): Q4 2019 Earnings Snapshot

Comments are closed.

Top